Radioimmunoassay (RIA) is an in vitro assay which helps to measures the presence of an antigen with very high sensitivity. In radioimmunoassay radioactive versions of a substance, or isotopes of the substance, are mixed with antibodies and inserted in a sample of the patient's blood. The amount of free isotope is then calculated to see how much of the original substance was in the blood. RIA has many applications, such as narcotics drug detection, blood bank screening for the hepatitis virus, early cancer detection, diagnosis and treatment of peptic ulcers and in research with brain chemicals called neurotransmitters.
The radioimmunoassay market is anticipated to grow in the forecast, the rising use of radioimmunoassay techniques in cancer diagnosis and advancements in medical research. In addition, it is also used in diagnosis of various other infectious diseases including neurodegenerative disorders, increasing RIA procedures in research centers, contract research organizations and pharmaceutical industries is expected to offer significant growth opportunities in the market during the forecast period.
The "Global Radioimmunoassay (RIA) Market Analysis to 2027" is a specialized and in-depth study of the in biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of radioimmunoassay market with detailed market segmentation by type, by application, end user and geography. The global radioimmunoassay market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading radioimmunoassay market players and offers key trends and opportunities in the market.
The global radioimmunoassay market is segmented on the basis of by type, by application, end user. Based on type, market is segmented into reagents and kits, analyzers. The radioimmunoassay market is categorized based on application in clinical diagnostics and research. Based on end user hospital, pharmaceutical industry, academics and clinical diagnostic labs.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global radioimmunoassay market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The radioimmunoassay market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting radioimmunoassay market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the radioimmunoassay market in these regions.
The reports cover key developments in the radioimmunoassay market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. Below mentioned is the list of few companies engaged in the radioimmunoassay market.
The report also includes the profiles of key radioimmunoassay market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
1. DIAsource ImmunoAssays
2. Beckman Coulter, Inc.
3. IBL International (A Tecan Company)
4. PerkinElmer, Inc.
5. DRG International, Inc.
6. MP Biomedicals, LLC
8. Euro Diagnostica AB
9. DiaSorin S.p.A.
10. EMD Millipore
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.